SCHEMBL5593629

SCHEMBL5593629

O=c1cc(Cl)sn1Cc1ccc2ccccc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KAT2B Q92831 4/20 0.49
KMT2A Q03164 1/20 0.47
DAO P14920 1/20 0.44
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
G6PD P11413 1/20 0.42
PKM P14618 1/20 0.42
HPGD P15428 1/20 0.42
ALOX15 P16050 1/20 0.42
HTT P42858 1/20 0.42
HSD17B10 Q99714 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
BACE1 P56817 1/20 0.42
GAA P10253 1/20 0.42
CTRC Q99895 1/20 0.41
CYP19A1 P11511 1/20 0.41
ACHE P22303 1/20 0.41
NPBWR1 P48145 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2A6 P11509 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL80967 0.83 KAT2B (0.58) KAT2BALDH1A1MAPTG6PDPKM
Hydrochloric Acid SCHEMBL9517520 0.82 KAT2B (0.56) KAT2BALDH1A1MAPTG6PDPKM
SCHEMBL678175 0.80 KAT2B (0.58) KAT2BKMT2AMAPT
SCHEMBL5593816 0.79 GAA (0.46) KAT2BKMT2ADAOGAACTRC
SCHEMBL5917427 0.78 ALDH1A1 (0.67) KMT2ADAOALDH1A1MAPTG6PD
SCHEMBL5593712 0.77 KAT2B (0.55) KAT2BALDH1A1MAPTG6PDPKM
SCHEMBL14640438 0.76 KAT2B (0.49) KAT2BKMT2AALDH1A1MAPTG6PD
SCHEMBL14640376 0.76 KAT2B (0.46) KAT2BALDH1A1MAPTG6PDPKM
SCHEMBL5593775 0.75 KAT2B (0.49) KAT2BALDH1A1MAPTG6PDPKM
SCHEMBL3655957 0.74 ALDH1A1 (0.57) KAT2BALDH1A1MAPTG6PDPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007001932-A2 SUBSTITUTED ISOTHIAZOLONES AS INHIBITORS OF CYTOSOLIC PHOSPHOLIPASE A2 JANSSEN PHARMACEUTICA N.V. (BE) 2007-01-04 WO disclosed
WO-2007001932-A2 SUBSTITUTED ISOTHIAZOLONES AS INHIBITORS OF CYTOSOLIC PHOSPHOLIPASE A2 JANSSEN PHARMACEUTICA N.V. (BE) 2007-01-04 WO disclosed
US-20060293374-A1 Substituted isothiazolones JANSSEN PHARMACEUTICA N.V. (BE) 2006-12-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060293374-A1 Substituted isothiazolones LTB4R2, PTGES2, CYSLTR2 KAT2B 1199/4885KMT2A 3563/4885DAO 2945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.